NCT06948955 2026-03-09Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal TumorsCogent Biosciences, Inc.Available
NCT04091295 2026-03-04BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of BreastAveni FoundationAvailable
NCT04566393 2026-01-28Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesxCuresAvailable
NCT05974410 2025-10-02Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology IncAvailable
NCT06872489 2025-07-23Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid TumorsSecond Life TherapeuticsAvailable